Identifying Adverse Events Using International Classification of Diseases, Tenth Revision Y Codes in Korea: A Cross-sectional Study
- Author:
Minsu OCK
1
;
Hwa Jung KIM
;
Bomin JEON
;
Ye Jee KIM
;
Hyun Mi RYU
;
Moo Song LEE
Author Information
- Publication Type:Original Article
- Keywords: Adverse event; International Classification of Diseases; Administrative claims; Healthcare; Republic of Korea
- MeSH: Clinical Coding; Cohort Studies; Cross-Sectional Studies; Delivery of Health Care; Immunoglobulins; International Classification of Diseases; Korea; National Health Programs; Republic of Korea; Vaccines
- From:Korean Journal of Preventive Medicine 2018;51(1):15-22
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: The use of administrative data is an affordable alternative to conducting a difficult large-scale medical-record review to estimate the scale of adverse events. We identified adverse events from 2002 to 2013 on the national level in Korea, using International Classification of Diseases, tenth revision (ICD-10) Y codes. METHODS: We used data from the National Health Insurance Service-National Sample Cohort (NHIS-NSC). We relied on medical treatment databases to extract information on ICD-10 Y codes from each participant in the NHIS-NSC. We classified adverse events in the ICD-10 Y codes into 6 types: those related to drugs, transfusions, and fluids; those related to vaccines and immunoglobulin; those related to surgery and procedures; those related to infections; those related to devices; and others. RESULTS: Over 12 years, a total of 20 817 adverse events were identified using ICD-10 Y codes, and the estimated total adverse event rate was 0.20%. Between 2002 and 2013, the total number of such events increased by 131.3%, from 1366 in 2002 to 3159 in 2013. The total rate increased by 103.9%, from 0.17% in 2002 to 0.35% in 2013. Events related to drugs, transfusions, and fluids were the most common (19 446, 93.4%), followed by those related to surgery and procedures (1209, 5.8%) and those related to vaccines and immunoglobulin (72, 0.3%). CONCLUSIONS: Based on a comparison with the results of other studies, the total adverse event rate in this study was significantly underestimated. Improving coding practices for ICD-10 Y codes is necessary to precisely monitor the scale of adverse events in Korea.
